Development of antibodies for detection of ERCC1 overexpression, a possible biomarker for cisplatin resistance of cancer

被引：0
|
作者：
Oishi, Takayuki [1 ]
Sasaki, Yuka [1 ]
Fujimori, Hiroaki [1 ]
Shibata, Noriko
Iwasa, Satoru
Nakao, Kazuhiko
Yamada, Yasuhide
Hiraoka, Nobuyoshi
Masutani, Mitsuko [1 ]
机构：
[1] Nagasaki Univ, Grad Sch, Dept Frontier Life Sci, Nagasaki, Japan
来源：
CANCER SCIENCE | 2018年 / 109卷
关键词：
ERCC1;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P-3371
引用
收藏
页码：1148 / 1148
页数：1
相关论文
共 50 条
  • [31] A Review of ERCC1 Gene in Bladder Cancer: Implications for Carcinogenesis and Resistance to Chemoradiotherapy
    Kawashima, Atsunari
    Takayama, Hitoshi
    Tsujimura, Akira
    ADVANCES IN UROLOGY, 2012, 2012
  • [32] ERCC1 Expression As a Predictive Marker of Cervical Cancer Treated with Cisplatin-based Chemoradiation
    Muallem, Mustafa Zelal
    Marnitz, Simone
    Richter, Rolf
    Koehler, Christhardt
    Sehouli, Jalid
    Arsenic, Ruza
    ANTICANCER RESEARCH, 2014, 34 (1A) : 401 - 406
  • [33] ERCC1 and the efficacy of cisplatin in patients with resected non-small cell lung cancer
    Li, Chunhong
    Liu, Meiyan
    Yan, An
    Liu, Wei
    Hou, Junjun
    Cai, Li
    Dong, Xiaoqun
    TUMOR BIOLOGY, 2014, 35 (12) : 12707 - 12712
  • [34] CHK2 and ERCC1 in the DNA Adduct Repair Pathway that Mediates Acquired Cisplatin Resistance
    Yu, Jing Jie
    Liang, Xiaobing
    Yan, Qing-Wu
    Reed, Eddie
    Fojo, Antonio Tito
    Guo, Ying
    He, Qi
    Mueller, Michael D.
    PLATINUM AND OTHER HEAVY METAL COMPOUNDS IN CANCER CHEMOTHERAPY: MOLECULAR MECHANISMS AND CLINICAL APPLICATIONS, 2009, : 189 - +
  • [35] ERCC1 and personalized medicine in lung cancer
    Ryu, Jeong Seon
    Memon, Azra
    Lee, Seul-Ki
    ANNALS OF TRANSLATIONAL MEDICINE, 2014, 2 (04)
  • [36] Evaluation of expression of ERCC1 in hepatocellular cancer
    Bas, E.
    Turhal, N. S.
    Er, O.
    Aliustaoglu, M.
    Seber, S.
    Dane, F.
    Korkmaz, T.
    Soyuer, I.
    Ozkara, S.
    Celikel, C.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [37] Clinical Perspectives of ERCC1 in Bladder Cancer
    Koutsoukos, Konstantinos
    Andrikopoulou, Angeliki
    Dedes, Nikos
    Zagouri, Flora
    Bamias, Aristotelis
    Dimopoulos, Meletios-Athanasios
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (22) : 1 - 18
  • [38] Truth About ERCC1 in Lung Cancer
    Tan, Daniel S. -W.
    Ng, Quan-Sing
    Tan, Iain B. -H.
    Lim, Soon-Thye
    Lim, Wan-Teck
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (10) : E162 - E162
  • [39] Randomized Prospective Biomarker Trial of ERCC1 for Comparing Platinum and Nonplatinum Therapy in Advanced Non-Small-Cell Lung Cancer: ERCC1 Trial (ET)
    Lee, Siow Ming
    Falzon, Mary
    Blackhall, Fiona
    Spicer, James
    Nicolson, Marianne
    Chaudhuri, Abhro
    Middleton, Gary
    Ahmed, Samreen
    Hicks, Jonathan
    Crosse, Barbara
    Napier, Mark
    Singer, Julian M.
    Ferry, David
    Lewanski, Conrad
    Forster, Martin
    Rolls, Sally-Ann
    Capitanio, Arrigo
    Rudd, Robin
    Iles, Natasha
    Ngai, Yenting
    Gandy, Michael
    Lillywhite, Rachel
    Hackshaw, Allan
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (04) : 402 - +
  • [40] A newly established monoclonal antibody against ERCC1 detects major isoforms of ERCC1 in gastric cancer
    Oishi, Takayuki
    Sasaki, Yuka
    Tong, Ying
    Chen, Lichao
    Onodera, Takae
    Iwasa, Satoru
    Udo, Emiko
    Furusato, Bungo
    Fujimori, Hiroaki
    Imamichi, Shoji
    Honda, Takuya
    Bessho, Tadayoshi
    Fukuoka, Junya
    Ashizawa, Kazuto
    Yanagihara, Kazuyoshi
    Nakao, Kazuhiko
    Yamada, Yasuhide
    Hiraoka, Nobuyoshi
    Masutani, Mitsuko
    GLOBAL HEALTH & MEDICINE, 2021, 3 (04): : 226 - 235
12345